Clinical Trial Update: Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Letrozole with Palbociclib or placebo in metastatic endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Letrozole (letrozole)
• Palbociclib (palbociclib)

Snippet

Sponsor: Nordic Society of Gynaecological Oncology - Clinical Trials Unit | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED